Eli Lilly Pulls The Plug On Antibody Study
Interactive Video
•
Health Sciences, Biology
•
University
•
Hard
Wayground Content
FREE Resource
The National Institute of Allergy and Infectious Diseases (NIAID) ended a study due to the low likelihood of the treatment's effectiveness for COVID-19 patients. The study involved an antibody treatment used alongside remdesivir, a drug approved for emergency use against the coronavirus.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What was the duration of the treatment study mentioned in the text?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
What did the study conclude about the effectiveness of the treatment for hospitalized COVID-19 patients?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
